Article: Bristol Investment Group Announces Investment Opinion on Biolase Technology, Inc.

NOTE TO EDITORS: The following is an investment opinion issued

by Bristol Investment Group

NEW YORK--(BUSINESS WIRE)--June 6, 2002

Bristol Investment Group Initiates Coverage of Biolase

Technology, Inc. (BLTI) with a BUY recommendation

Bristol Investment Group, the New York-based investment banking firm, has initiated coverage of Biolase Technology, Inc. (NasdaqNM: BLTI) with a "BUY" recommendation. Bristol set a twelve-month target price of $9.

About Biolase Technology

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!